Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study

2004 ◽  
Vol 92 (2) ◽  
pp. 644-647 ◽  
Author(s):  
Katherine Y Look ◽  
Alan Sandler ◽  
John A Blessing ◽  
Joseph A Lucci ◽  
Peter G Rose
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Gynecologic Oncology ◽  
Uterine Leiomyosarcoma ◽  
Gynecologic Oncology Group ◽  
Second Line ◽  
Oncology Group ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

2006 ◽  
Vol 103 (2) ◽  
pp. 523-526 ◽  
Author(s):  
Paula M. Fracasso ◽  
John A. Blessing ◽  
Kelly L. Molpus ◽  
Lisa M. Adler ◽  
Joel I. Sorosky ◽  
...  
Keyword(s):  
Endometrial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Second Line ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document